Scientists Discover Ancient 15-Ingredient Formula That Could Help Destroy Drug-Resistant Cancer

Scientists investigating one of the world’s most difficult-to-treat cancers have uncovered an unexpected candidate that could open a new direction in cancer research. It comes from a traditional Chinese medicine formula containing 15 ingredients, which has now shown an ability to attack cancer cells that have developed resistance to chemotherapy. The laboratory findings have caught attention because drug resistance remains one of the biggest obstacles facing patients with certain forms of cancer.

The formulation, known as Huayu Wan, appeared to trigger a destructive process inside resistant cancer cells, causing them to break down and die. Researchers also tested it in mice carrying esophageal cancer tumors and observed reduced tumor growth. Even more interestingly, combining the traditional formula with an existing immunotherapy treatment produced stronger results. However, the research is still at an experimental stage, and scientists have yet to establish whether the same effects can be achieved safely in human patients.

Scientists Test Traditional Chinese Medicine Against Resistant Cancer

Esophageal squamous cell carcinoma (ESCC) is the most common form of esophageal cancer worldwide. The disease is particularly prevalent in parts of Asia and developing nations, where it remains a significant health challenge. One commonly used chemotherapy drug for treating this cancer is cisplatin, which works by damaging cancer cells and preventing them from continuing to grow. However, some tumors eventually develop resistance, allowing malignant cells to survive treatment and continue multiplying.

This resistance can create serious difficulties for patients because medications that initially worked may become less effective over time. Researchers from Shaoxing University in China investigated whether Huayu Wan could help address this problem by targeting the biological mechanisms that allow cancer cells to withstand chemotherapy. Their study, published in Frontiers in Immunology, examined the formulation’s effects on human and mouse cancer cells that had already developed resistance to cisplatin.

The researchers explained the consequences of this resistance in their study, writing: “Once resistance develops, patients are more likely to experience reduced responses to subsequent treatment and unfavorable survival outcomes.” Their investigation focused on understanding how Huayu Wan might interfere with the survival mechanisms of these cancer cells. The team also wanted to determine whether the formulation could produce effects strong enough to suppress tumor growth in living animals.

What Is The Traditional Formula Huayu Wan?

Huayu Wan is a traditional Chinese medicine formulation containing 15 ingredients derived from two established remedies, Taohong Siwu and Didang decoctions. These preparations have historical associations with treating abdominal masses and tumor-like conditions within traditional Chinese medicine. Huayu Wan has continued to be used in modern clinical settings in China as part of traditional approaches to treating tumors, although its precise biological effects have not been fully understood.

Researchers have previously investigated the formulation’s potential antitumor properties, including experiments involving animal models. However, relatively little has been established about the molecular mechanisms responsible for its observed effects. The latest investigation sought to address that gap by examining how the formulation interacted with cancer cells that had become resistant to a conventional chemotherapy medication.

The team concentrated on the possibility that Huayu Wan could interfere with cellular defenses responsible for protecting cancer cells from damage. Their experiments eventually pointed toward ferroptosis, a type of programmed cell death involving iron and oxidative damage. This discovery provided researchers with a possible explanation for how the traditional formulation affected resistant cancer cells and why its effects became stronger under certain experimental conditions.

Laboratory Experiments Showed Cancer Cells Losing Their Defenses

The researchers began by growing human and mouse esophageal cancer cells that had developed resistance to cisplatin. They exposed the cells to different concentrations of Huayu Wan and monitored their activity and growth over time. The results showed that the formulation suppressed the cancer cells, with stronger antitumor effects appearing when higher concentrations were used or when exposure lasted longer.

The team then investigated what was happening inside the treated cells. Their findings suggested that Huayu Wan interfered with antioxidant defense mechanisms that normally help cells protect themselves against oxidative damage. These defenses involve glutathione, a chemical that plays an important role in maintaining the balance between damaging oxidative reactions and the systems that neutralize them. When these protective mechanisms become disrupted, cells can become increasingly vulnerable to damage.

Researchers also observed changes involving ferritin, a protein responsible for storing iron inside cells. Their findings suggested that Huayu Wan helped release iron from these internal stores, contributing to reactions that increase damage to cell membranes. This process, known as lipid peroxidation, involves the oxidative destruction of fats that form an essential part of cellular membranes. Together, these changes appeared to push the resistant cancer cells toward ferroptosis.

How Ferroptosis Could Help Destroy Resistant Cancer Cells

Ferroptosis is a form of programmed cell death that depends on iron and the buildup of oxidative damage. It has attracted growing scientific interest because cancer cells can sometimes be vulnerable to this process, particularly when their antioxidant defenses are disrupted. The mechanism identified in the Huayu Wan experiments suggests that the formulation could interfere with two protective systems at the same time, making it harder for resistant cancer cells to survive.

Disrupting Glutathione Protection

Glutathione helps cells control oxidative stress by neutralizing potentially damaging substances. Cancer cells rely on antioxidant systems to maintain their internal balance and prevent excessive damage to important cellular structures. The researchers found evidence that Huayu Wan disrupted glutathione-related defenses, leaving the treated cancer cells less capable of controlling oxidative damage.

Increasing Iron-Driven Cellular Damage

The researchers also identified changes involving ferritin and the release of stored iron. As more iron becomes available inside a cell, it can contribute to chemical reactions that accelerate lipid peroxidation. This creates additional damage to cellular membranes and can push vulnerable cells toward ferroptosis. The researchers believe the combination of weakened antioxidant protection and increased iron availability explains much of the formulation’s observed antitumor activity.

The team described the mechanism in their research, writing: “By coupling these two processes, Huayu Wan innovatively forces a breakdown of the cancer cells’ redox defenses.” They also explained that the interaction between lipid peroxidation and iron release helped drive ferroptotic cell death. Although these findings provide a possible explanation for the laboratory results, further research will be needed to establish how reliably the mechanism operates in living human tissue.

Mouse Experiments Reveal Reduced Tumor Growth

After observing the effects in laboratory-grown cancer cells, the researchers investigated whether Huayu Wan could also suppress tumors in living animals. They implanted mice with cisplatin-resistant esophageal cancer cells before treating them with the traditional formulation. The team then compared the treated animals with mice that had not received the treatment to determine whether the formulation affected tumor development.

The results showed that mice receiving Huayu Wan experienced suppressed tumor growth compared with untreated animals. Researchers also observed reductions in tumor weight, providing additional evidence that the formulation could influence resistant cancer cells beyond laboratory conditions. These results supported the team’s earlier observations and suggested that the biological effects seen in cell cultures might also occur within an animal model.

However, animal experiments have important limitations when predicting how a treatment will work in people. Differences in metabolism, immune responses, and drug processing can influence how the human body reacts to a substance. A formulation that reduces tumor growth in mice may produce different results in clinical trials, and its safety profile also needs to be established. The findings therefore offer an early research lead rather than proof that Huayu Wan can treat cancer in humans.

Combining The Formula With Immunotherapy Produced Stronger Results

Another finding emerged when researchers examined the immune environment surrounding the treated tumors. They discovered that tumors exposed to Huayu Wan contained increased numbers of CD8+ T cells, which are immune cells involved in recognizing and attacking abnormal cells. This suggested that the formulation might influence the body’s immune response alongside its direct effects on cancer cells.

The researchers then investigated whether Huayu Wan could work alongside anti-PD-1 immunotherapy. This treatment targets a protein pathway that cancer cells can exploit to avoid attacks from the immune system. Blocking PD-1 can help restore the ability of certain immune cells to recognize and attack cancer, making the treatment an established area of investigation in several types of cancer.

When the researchers combined Huayu Wan with anti-PD-1 treatment, they observed greater suppression of tumor growth than with either treatment alone. The combination also produced a larger reduction in tumor weight. These findings suggest that the formulation could potentially influence several processes involved in tumor development, including cancer cell survival and immune activity.

However, the results do not establish that combining Huayu Wan with immunotherapy would benefit human patients. Researchers must first determine whether the interaction is safe, identify appropriate doses, and investigate whether the same effects can be reproduced in more advanced studies. The combination remains an experimental approach that requires substantial further investigation.

What Researchers Still Need To Establish

Despite the encouraging laboratory and animal findings, Huayu Wan has several major research hurdles ahead. The study has not demonstrated that the formulation can safely eliminate drug-resistant cancer cells in people, nor has it established whether patients would experience meaningful improvements in survival. Researchers will need to investigate its ingredients individually and together to understand which compounds contribute to its effects.

Some of the most important questions that future investigations must address include:

• Human safety: Researchers must determine whether the formulation causes harmful side effects or unwanted reactions in patients.
• Appropriate dosing: The concentrations used in laboratory experiments cannot automatically be translated into safe doses for human treatment.
• Drug interactions: Scientists need to understand how the formulation interacts with cisplatin, immunotherapy, and other cancer medications.
• Long-term effectiveness: Further studies must establish whether the observed effects can be sustained and whether tumors eventually develop resistance.
• Clinical benefits: Human trials will be necessary to determine whether Huayu Wan can improve treatment outcomes for people with esophageal cancer.

These questions are particularly important because Huayu Wan contains multiple ingredients that could have different biological effects. Researchers must establish how the formulation behaves inside the human body and whether its individual components work together safely. Patients currently receiving chemotherapy or immunotherapy should not replace prescribed treatments with traditional preparations based on experimental findings.

An Ancient Remedy Offers A New Direction For Cancer Research

The Shaoxing University study adds to ongoing investigations into natural compounds and their potential role in addressing chemotherapy resistance. The researchers noted that natural products are increasingly being studied for their ability to influence cancer cell survival pathways and potentially increase sensitivity to existing treatments. Their findings suggest that Huayu Wan deserves further investigation because of its apparent effects on ferroptosis and the immune environment surrounding tumors.

The team concluded that the formulation could represent a potential strategy against cisplatin-resistant ESCC, while emphasizing the need for additional research. Its combination with anti-PD-1 treatment also provides another avenue worth examining. However, the current evidence remains limited to laboratory experiments and animal research, meaning there is still a considerable distance between these findings and a treatment that doctors could safely prescribe.

For now, the most significant finding is the possible mechanism behind Huayu Wan’s effects. Researchers have identified a traditional formulation that appears capable of weakening cancer cells’ protective systems and triggering a form of cell death. Whether that discovery can eventually help patients will depend on what happens when scientists move beyond the laboratory and begin testing the treatment’s safety and effectiveness in humans.

Sources:

Zhu, T., Wang, B., Wang, H., Ding, J., Xu, Y., Xu, J., Dong, L., Wang, X., Yu, G., & Li, Z. (2026b). Huayu Wan induces ferroptosis and enhances anti-PD-1 efficacy in cisplatin-resistant esophageal squamous cell carcinoma. Frontiers in Immunology, 17. https://doi.org/10.3389/fimmu.2026.1967436